Variant report

Variant	nsv112229
Chromosome Location	chr17:63095123-63104894
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:744)
CpG islands
(count:427)
Chromatin interactive
region (count:32)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:744 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:63096693-63096919	HepG2	liver:	n/a	n/a
2	ARID3A	chr17:63096384-63096860	K562	blood:	n/a	n/a
3	ATF2	chr17:63095985-63096878	GM12878	blood:	n/a	n/a
4	ATF2	chr17:63095924-63096675	GM12878	blood:	n/a	n/a
5	ATF3	chr17:63096692-63096933	K562	blood:	n/a	n/a
6	BATF	chr17:63096012-63096353	GM12878	blood:	n/a	n/a
7	BATF	chr17:63096004-63096642	GM12878	blood:	n/a	n/a
8	BCL11A	chr17:63095990-63096579	GM12878	blood:	n/a	n/a
9	BCL11A	chr17:63096483-63096720	GM12878	blood:	n/a	chr17:63096597-63096606
10	BCL11A	chr17:63096032-63096351	GM12878	blood:	n/a	n/a
11	BCL3	chr17:63096007-63096919	A549	lung:	n/a	chr17:63096771-63096784 chr17:63096763-63096772 chr17:63096597-63096606 chr17:63096816-63096829
12	BCL3	chr17:63095965-63096414	GM12878	blood:	n/a	n/a
13	BCLAF1	chr17:63096002-63097061	GM12878	blood:	n/a	chr17:63096771-63096784 chr17:63096763-63096772 chr17:63096597-63096606 chr17:63096816-63096829
14	BCLAF1	chr17:63095984-63096941	GM12878	blood:	n/a	chr17:63096771-63096784 chr17:63096763-63096772 chr17:63096597-63096606 chr17:63096816-63096829
15	BHLHE40	chr17:63096138-63096924	A549	lung:	n/a	n/a
16	BHLHE40	chr17:63102712-63103085	K562	blood:	n/a	n/a
17	BHLHE40	chr17:63096211-63096987	HepG2	liver:	n/a	n/a
18	BHLHE40	chr17:63096152-63097138	K562	blood:	n/a	n/a
19	BHLHE40	chr17:63096003-63096984	GM12878	blood:	n/a	n/a
20	BRCA1	chr17:63096158-63096902	Hela-S3	cervix:	n/a	n/a
21	CCNT2	chr17:63102699-63102969	K562	blood:	n/a	n/a
22	CCNT2	chr17:63096632-63096976	K562	blood:	n/a	n/a
23	CEBPB	chr17:63102693-63103202	IMR90	lung:	n/a	n/a
24	CEBPB	chr17:63102689-63103153	ECC-1	luminal epithelium:	n/a	n/a
25	CEBPB	chr17:63102690-63103110	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr17:63102673-63103204	MCF-7	breast:	n/a	n/a
27	CEBPB	chr17:63102791-63103063	A549	lung:	n/a	n/a
28	CEBPB	chr17:63102695-63103056	K562	blood:	n/a	n/a
29	CEBPB	chr17:63098186-63098365	A549	lung:	n/a	n/a
30	CEBPB	chr17:63102584-63103255	ECC-1	luminal epithelium:	n/a	n/a
31	CEBPB	chr17:63095946-63096847	GM12878	blood:	n/a	n/a
32	CEBPB	chr17:63102758-63102928	HepG2	liver:	n/a	n/a
33	CEBPB	chr17:63102625-63103187	MCF-7	breast:	n/a	n/a
34	CEBPB	chr17:63096724-63096924	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr17:63099967-63100124	HepG2	liver:	n/a	chr17:63100018-63100029
36	CEBPD	chr17:63096624-63096957	HepG2	liver:	n/a	n/a
37	CHD1	chr17:63096261-63096933	GM12878	blood:	n/a	n/a
38	CHD2	chr17:63096675-63096978	H1-hESC	embryonic stem cell:	n/a	n/a
39	CHD2	chr17:63096759-63097201	HepG2	liver:	n/a	n/a
40	CHD2	chr17:63096104-63097082	Hela-S3	cervix:	n/a	n/a
41	CHD2	chr17:63096837-63096903	K562	blood:	n/a	n/a
42	CHD2	chr17:63096105-63096977	GM12878	blood:	n/a	n/a
43	CREB1	chr17:63096723-63097004	A549	lung:	n/a	n/a
44	CREB1	chr17:63096568-63097068	A549	lung:	n/a	n/a
45	CTCF	chr17:63096727-63096978	Hela-S3	cervix:	n/a	chr17:63096833-63096849 chr17:63096832-63096850 chr17:63096837-63096850 chr17:63096766-63096779 chr17:63096834-63096847 chr17:63096817-63096830 chr17:63096827-63096848 chr17:63096834-63096847
46	CTCF	chr17:63096736-63096987	Medullo	brain:	n/a	chr17:63096833-63096849 chr17:63096832-63096850 chr17:63096837-63096850 chr17:63096766-63096779 chr17:63096834-63096847 chr17:63096817-63096830 chr17:63096827-63096848 chr17:63096834-63096847
47	CTCF	chr17:63096520-63096670	GM12873	blood:	n/a	n/a
48	CTCF	chr17:63096180-63096330	HUVEC	blood vessel:	n/a	n/a
49	CTCF	chr17:63096780-63096930	WERI-Rb-1	eye:	n/a	chr17:63096833-63096849 chr17:63096832-63096850 chr17:63096837-63096850 chr17:63096834-63096847 chr17:63096817-63096830 chr17:63096827-63096848 chr17:63096834-63096847
50	CTCF	chr17:63096740-63096890	HMEC	breast:	n/a	chr17:63096833-63096849 chr17:63096832-63096850 chr17:63096837-63096850 chr17:63096766-63096779 chr17:63096834-63096847 chr17:63096817-63096830 chr17:63096827-63096848 chr17:63096834-63096847

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:63097195-63097245	K562	blood:	n/a
2	chr17:63102478-63102528	Caco-2	colon:	n/a
3	chr17:63100218-63100268	BJ	skin:	n/a
4	chr17:63096940-63096990	ECC-1	luminal epithelium:	n/a
5	chr17:63096911-63096961	AG04449	skin:	fetal
6	chr17:63096911-63096961	HRE	kidney:	n/a
7	chr17:63097125-63097175	H1-hESC	embryonic stem cell:	embryo
8	chr17:63097125-63097175	GM12891	blood:	n/a
9	chr17:63097195-63097245	Hela-S3	cervix:	n/a
10	chr17:63102478-63102528	HCM	heart:	n/a
11	chr17:63097125-63097175	Caco-2	colon:	n/a
12	chr17:63102478-63102528	MCF-7	breast:	n/a
13	chr17:63100218-63100268	SAEC	small airway:	n/a
14	chr17:63097195-63097245	GM12878	blood:	n/a
15	chr17:63096940-63096990	GM19239	blood:	n/a
16	chr17:63097195-63097245	NHBE	bronchial:	n/a
17	chr17:63096940-63096990	ProgFib	skin:	n/a
18	chr17:63096635-63096685	NT2-D1	testis:	n/a
19	chr17:63097195-63097245	AG09309	skin:	n/a
20	chr17:63097125-63097175	HIPEpiC	eye:	n/a
21	chr17:63100218-63100268	PANC-1	pancreas:	n/a
22	chr17:63096635-63096685	GM12891	blood:	n/a
23	chr17:63096940-63096990	HPAEpiC	pulmonary alveolar:	n/a
24	chr17:63096940-63096990	MCF10A-Er-Src	breast:	n/a
25	chr17:63096911-63096961	GM19239	blood:	n/a
26	chr17:63100218-63100268	AoSMC	blood vessel:	n/a
27	chr17:63097125-63097175	BJ	skin:	n/a
28	chr17:63100218-63100268	HRE	kidney:	n/a
29	chr17:63100218-63100268	HepG2	liver:	n/a
30	chr17:63096940-63096990	PrEC	prostate:	n/a
31	chr17:63096911-63096961	HL-60	blood:	n/a
32	chr17:63096635-63096685	HCF	heart:	n/a
33	chr17:63096635-63096685	Caco-2	colon:	n/a
34	chr17:63100218-63100268	PrEC	prostate:	n/a
35	chr17:63096940-63096990	NHBE	bronchial:	n/a
36	chr17:63097125-63097175	T-47D	breast:	n/a
37	chr17:63096911-63096961	PANC-1	pancreas:	n/a
38	chr17:63096635-63096685	SKMC	muscle:	n/a
39	chr17:63097125-63097175	K562	blood:	n/a
40	chr17:63102478-63102528	SKMC	muscle:	n/a
41	chr17:63097125-63097175	AG09319	gingival:	n/a
42	chr17:63096940-63096990	HEEpiC	esophagus:	n/a
43	chr17:63096911-63096961	T-47D	breast:	n/a
44	chr17:63102478-63102528	T-47D	breast:	n/a
45	chr17:63097195-63097245	A549	lung:	n/a
46	chr17:63100218-63100268	AG04450	lung:	fetal
47	chr17:63100218-63100268	AG09319	gingival:	n/a
48	chr17:63096911-63096961	HUVEC	blood vessel:	n/a
49	chr17:63096635-63096685	NHDF-neo	bronchial:	n/a
50	chr17:63100218-63100268	HAEpiC	amniotic membrane:	n/a

(count:32 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:63099337..63101171-chr17:63120378..63121953,2	MCF-7	breast:
2	chr17:63094877..63096816-chr17:63119599..63121828,2	K562	blood:
3	chr17:62971246..62972147-chr17:63096451..63097018,2	MCF-7	breast:
4	chr17:63097331..63099925-chr17:63102764..63104387,2	MCF-7	breast:
5	chr17:63094402..63096834-chr17:63124738..63127386,3	MCF-7	breast:
6	chr17:63094766..63097094-chr17:63098235..63100205,2	MCF-7	breast:
7	chr17:62967915..62971440-chr17:63104583..63107908,3	MCF-7	breast:
8	chr17:63051381..63054935-chr17:63092846..63100708,11	MCF-7	breast:
9	chr17:63097331..63099925-chr17:63102764..63104387,2	MCF-7	breast:
10	chr17:63099430..63102253-chr17:63117959..63120208,2	MCF-7	breast:
11	chr17:63051324..63054439-chr17:63103781..63105760,3	MCF-7	breast:
12	chr17:62969521..62973434-chr17:63095329..63098484,3	MCF-7	breast:
13	chr17:63098560..63101112-chr17:63116084..63117687,2	MCF-7	breast:
14	chr17:63097236..63098868-chr17:63102813..63104467,2	MCF-7	breast:
15	chr17:63096447..63097264-chr17:63133141..63133975,2	K562	blood:
16	chr17:63103004..63106074-chr17:63118329..63120568,5	MCF-7	breast:
17	chr17:63056815..63059165-chr17:63094050..63096835,2	MCF-7	breast:
18	chr17:62969603..62971143-chr17:63093866..63096603,2	K562	blood:
19	chr17:63013597..63016405-chr17:63092647..63095206,2	MCF-7	breast:
20	chr17:63103464..63106630-chr17:63116614..63119834,3	K562	blood:
21	chr17:63035178..63037287-chr17:63102976..63105105,2	MCF-7	breast:
22	chr17:63101310..63103493-chr17:63108263..63110004,2	K562	blood:
23	chr17:62965395..62967905-chr17:63101570..63104162,3	MCF-7	breast:
24	chr17:63097236..63098868-chr17:63102813..63104467,2	MCF-7	breast:
25	chr17:63090606..63093224-chr17:63094471..63096809,2	K562	blood:
26	chr17:63096537..63097262-chr17:63133022..63134065,3	MCF-7	breast:
27	chr17:63098255..63100421-chr17:63117323..63119629,3	MCF-7	breast:
28	chr17:63051785..63054961-chr17:63094963..63102322,8	MCF-7	breast:
29	chr17:62773091..62773822-chr17:63096388..63096888,2	K562	blood:
30	chr17:63088577..63090668-chr17:63093968..63095609,2	MCF-7	breast:
31	chr17:63100401..63103168-chr17:63151819..63153531,2	MCF-7	breast:
32	chr17:63050336..63051938-chr17:63095270..63097179,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RGS9-1	chr17:63097174-63097414	XLOC_012281

No data

Variant related genes	Relation type
ENSG00000263470	TF binding region
ENSG00000263470	CpG island
ENSG00000263470	chromatin interactions
ENSG00000108370	chromatin interactions
ENSG00000120063	chromatin interactions
ENSG00000214174	chromatin interactions
SOX9	miRNA target sites

Extended variants
information (count: 388 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:388 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs60051761	chr17:63095131-63095132	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs377458990	chr17:63095132-63095133	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs199611202	chr17:63095135-63095136	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs375273127	chr17:63095140-63095141	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs12601011	chr17:63095204-63095205	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs566329524	chr17:63095211-63095212	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs538747489	chr17:63095252-63095253	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs558728183	chr17:63095325-63095326	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs374280733	chr17:63095343-63095344	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs184660407	chr17:63095430-63095431	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs113618359	chr17:63095445-63095446	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs577539944	chr17:63095465-63095466	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs534833060	chr17:63095516-63095517	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs141245136	chr17:63095591-63095592	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs546674564	chr17:63095592-63095593	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs115748830	chr17:63095616-63095617	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs145417449	chr17:63095664-63095665	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs535479816	chr17:63095739-63095740	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs559916908	chr17:63095780-63095781	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs576585970	chr17:63095885-63095886	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs34202215	chr17:63095895-63095896	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs376966835	chr17:63095905-63095906	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs575857197	chr17:63095942-63095943	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs189143017	chr17:63095950-63095951	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs73994706	chr17:63095965-63095966	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs72013690	chr17:63095966-63095967	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs73994707	chr17:63095967-63095968	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs201739652	chr17:63095969-63095970	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs71979247	chr17:63095971-63095972	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs10591008	chr17:63095980-63095981	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs398031327	chr17:63095982-63095983	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs6504277	chr17:63096005-63096006	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs199864763	chr17:63096051-63096052	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs138138571	chr17:63096170-63096171	Enhancers Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs142621053	chr17:63096318-63096319	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs145954520	chr17:63096319-63096320	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs547275279	chr17:63096326-63096327	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs567161612	chr17:63096373-63096374	Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs181557863	chr17:63096420-63096421	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs138377069	chr17:63096477-63096478	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs185629872	chr17:63096495-63096496	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs149280629	chr17:63096500-63096501	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs62062507	chr17:63096526-63096527	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs12453609	chr17:63096542-63096543	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs573741624	chr17:63096558-63096559	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs533842517	chr17:63096570-63096571	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs553687961	chr17:63096572-63096573	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs376470574	chr17:63096593-63096594	Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs576722065	chr17:63096612-63096613	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs190724403	chr17:63096613-63096614	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Neuroblastoma	18923191	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Breast cancer	21509527	CNVD
Chordoma	18071362	CNVD
Cancer	16751803	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	21523713	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Breast cancer	16397240	CNVD
Breast cancer	17603634	CNVD
Urothelial carcinoma	18382360	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Breast cancer	21858162	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Breast cancer	16620391	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
Cancer	21129771	CNVD
Breast cancer	16417655	CNVD
Myelofibrosis	22110671	CNVD
Intracranial ependymoma	16609018	CNVD
Congenital generalized hypertrichosis terminalis	19463983	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:757 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:63082200-63096400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr17:63082800-63095400	Weak transcription	Sigmoid Colon	Sigmoid Colon
3	chr17:63082800-63095400	Weak transcription	Small Intestine	intestine
4	chr17:63089400-63095400	Weak transcription	Duodenum Mucosa	Duodenum
5	chr17:63090800-63095200	Weak transcription	Rectal Mucosa Donor 29	rectum
6	chr17:63092200-63095400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
7	chr17:63092600-63095200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
8	chr17:63092800-63096000	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
9	chr17:63093600-63095400	Weak transcription	Stomach Mucosa	stomach
10	chr17:63093800-63095200	Weak transcription	A549	lung
11	chr17:63093800-63095400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr17:63094000-63096000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr17:63094400-63096000	Weak transcription	Primary T cells from cord blood	blood
14	chr17:63094600-63095400	Weak transcription	Brain Anterior Caudate	brain
15	chr17:63095000-63096200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr17:63095000-63096200	Enhancers	Muscle Satellite Cultured Cells	--
17	chr17:63095200-63095400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr17:63095200-63095400	Enhancers	Osteobl	bone
19	chr17:63095200-63095600	Enhancers	A549	lung
20	chr17:63095200-63096000	Enhancers	Primary T helper naive cells from peripheral blood	blood
21	chr17:63095200-63096000	Enhancers	Primary T helper cells PMA-I stimulated	--
22	chr17:63095200-63096000	Enhancers	Skeletal Muscle Female	skeletal muscle
23	chr17:63095200-63096200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr17:63095200-63096200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr17:63095200-63096200	Enhancers	Primary B cells from peripheral blood	blood
26	chr17:63095200-63096200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
27	chr17:63095200-63096200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
28	chr17:63095200-63096200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
29	chr17:63095200-63096200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr17:63095200-63096200	Enhancers	Adipose Nuclei	Adipose
31	chr17:63095200-63096200	Enhancers	Colon Smooth Muscle	Colon
32	chr17:63095200-63096200	Enhancers	Rectal Mucosa Donor 29	rectum
33	chr17:63095200-63096200	Enhancers	Rectal Mucosa Donor 31	rectum
34	chr17:63095200-63096200	Enhancers	GM12878-XiMat	blood
35	chr17:63095200-63096200	Enhancers	NH-A	brain
36	chr17:63095200-63096200	Enhancers	NHEK	skin
37	chr17:63095400-63095600	Enhancers	Sigmoid Colon	Sigmoid Colon
38	chr17:63095400-63095600	Flanking Active TSS	NHDF-Ad	bronchial
39	chr17:63095400-63095800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr17:63095400-63095800	Flanking Active TSS	Osteobl	bone
41	chr17:63095400-63096000	Enhancers	Primary T cells fromperipheralblood	blood
42	chr17:63095400-63096000	Enhancers	Primary T helper cells fromperipheralblood	blood
43	chr17:63095400-63096000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
44	chr17:63095400-63096000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr17:63095400-63096000	Enhancers	Brain Anterior Caudate	brain
46	chr17:63095400-63096000	Enhancers	Duodenum Mucosa	Duodenum
47	chr17:63095400-63096000	Enhancers	Hela-S3	cervix
48	chr17:63095400-63096200	Enhancers	Breast Myoepithelial Primary Cells	Breast
49	chr17:63095400-63096200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
50	chr17:63095400-63096200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links